The diabetes mellitus–atherosclerosis connection: The role of lipid and glucose metabolism and chronic inflammation A Poznyak, AV Grechko, P Poggio, VA Myasoedova, V Alfieri, AN Orekhov International journal of molecular sciences 21 (5), 1835, 2020 | 741 | 2020 |
Platelet and endothelial activation as potential mechanisms behind the thrombotic complications of COVID-19 patients P Canzano, M Brambilla, B Porro, N Cosentino, E Tortorici, S Vicini, ... Basic to Translational Science 6 (3), 202-218, 2021 | 203 | 2021 |
Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm E Branchetti, P Poggio, R Sainger, E Shang, JB Grau, BM Jackson, EK Lai, ... Cardiovascular research 100 (2), 316-324, 2013 | 136 | 2013 |
Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis E Branchetti, R Sainger, P Poggio, JB Grau, J Patterson-Fortin, JE Bavaria, ... Arteriosclerosis, thrombosis, and vascular biology 33 (2), e66-e74, 2013 | 124 | 2013 |
TGF-β1 Induces Endothelial Cell Apoptosis by Shifting VEGF Activation of p38MAPK from the Prosurvival p38β to Proapoptotic p38α G Ferrari, V Terushkin, MJ Wolff, X Zhang, C Valacca, P Poggio, ... Molecular Cancer Research 10 (5), 605-614, 2012 | 109 | 2012 |
Insights into the use of biomarkers in calcific aortic valve disease E Beckmann, JB Grau, R Sainger, P Poggio, G Ferrari The Journal of heart valve disease 19 (4), 441, 2010 | 98 | 2010 |
Analysis of osteopontin levels for the identification of asymptomatic patients with calcific aortic valve disease JB Grau, P Poggio, R Sainger, WJ Vernick, WF Seefried, E Branchetti, ... The Annals of thoracic surgery 93 (1), 79-86, 2012 | 95 | 2012 |
Evidence of SARS-CoV-2 transcriptional activity in cardiomyocytes of COVID-19 patients without clinical signs of cardiac involvement GP Bulfamante, GL Perrucci, M Falleni, E Sommariva, D Tosi, C Martinelli, ... Biomedicines 8 (12), 626, 2020 | 90 | 2020 |
Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation R Sainger, JB Grau, E Branchetti, P Poggio, WF Seefried, BC Field, ... Journal of cellular physiology 227 (6), 2595-2604, 2012 | 72 | 2012 |
Sex-specific features of calcific aortic valve disease VI Summerhill, D Moschetta, AN Orekhov, P Poggio, VA Myasoedova International Journal of Molecular Sciences 21 (16), 5620, 2020 | 65 | 2020 |
Osteopontin–CD44v6 interaction mediates calcium deposition via phospho-akt in valve interstitial cells from patients with noncalcified aortic valve sclerosis P Poggio, E Branchetti, JB Grau, EK Lai, RC Gorman, JH Gorman III, ... Arteriosclerosis, thrombosis, and vascular biology 34 (9), 2086-2094, 2014 | 65 | 2014 |
Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis P Poggio, R Sainger, E Branchetti, JB Grau, EK Lai, RC Gorman, ... Cardiovascular research 98 (3), 402-410, 2013 | 65 | 2013 |
Anti-atherosclerotic effects of a phytoestrogen-rich herbal preparation in postmenopausal women VA Myasoedova, TV Kirichenko, AA Melnichenko, VA Orekhova, A Ravani, ... International journal of molecular sciences 17 (8), 1318, 2016 | 62 | 2016 |
Efficacy and safety of bempedoic acid in patients with hypercholesterolemia: systematic review and meta‐analysis of randomized controlled trials A Di Minno, R Lupoli, I Calcaterra, P Poggio, F Forte, G Spadarella, ... Journal of the American Heart Association 9 (15), e016262, 2020 | 60 | 2020 |
Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis N Perrot, V Valerio, D Moschetta, SM Boekholdt, C Dina, HY Chen, ... Basic to Translational Science 5 (7), 649-661, 2020 | 60 | 2020 |
Novel pharmacological targets for calcific aortic valve disease: Prevention and treatments VA Myasoedova, AL Ravani, B Frigerio, V Valerio, D Moschetta, P Songia, ... Pharmacological research 136, 74-82, 2018 | 60 | 2018 |
Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and controls P Poggio, JB Grau, BC Field, R Sainger, WF Seefried, F Rizzolio, ... Journal of cellular physiology 226 (8), 2139-2149, 2011 | 57 | 2011 |
CaMKII activity in the inflammatory response of cardiac diseases MR Rusciano, E Sommariva, V Douin-Echinard, M Ciccarelli, P Poggio, ... International Journal of Molecular Sciences 20 (18), 4374, 2019 | 54 | 2019 |
Circulating soluble receptor for advanced glycation end product identifies patients with bicuspid aortic valve and associated aortopathies E Branchetti, JE Bavaria, JB Grau, RE Shaw, P Poggio, EK Lai, ND Desai, ... Arteriosclerosis, thrombosis, and vascular biology 34 (10), 2349-2357, 2014 | 51 | 2014 |
Dephosphorylation of circulating human osteopontin correlates with severe valvular calcification in patients with calcific aortic valve disease R Sainger, JB Grau, P Poggio, E Branchetti, JE Bavaria, JH Gorman III, ... Biomarkers 17 (2), 111-118, 2012 | 50 | 2012 |